Information for "State of the art in benefit–risk analysis: Medicines"
Basic information
| Display title | State of the art in benefit–risk analysis: Medicines |
| Default sort key | State of the art in benefit–risk analysis: Medicines |
| Page length (in bytes) | 45,750 |
| Page ID | 5540 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Testiwiki item ID | None |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | EssiV (talk | contribs) |
| Date of page creation | 21:53, 19 April 2012 |
| Latest editor | EssiV (talk | contribs) |
| Date of latest edit | 12:40, 20 April 2012 |
| Total number of edits | 14 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Page properties
| Transcluded templates (7) | Templates used on this page: |
